Statistics from Altmetric.com
Bleeding versus thromboembolic protection in atrial fibrillation and coronary stent procedures
Five to 8% of people undergoing percutaneous coronary intervention (PCI) also have atrial fibrillation (AF). The optimal antiplatelet / anticoagulant regimen in these individuals remains unclear as stroke and stent thrombosis prevention need to be balanced against the risks of major bleeding. The PIONEER AF-PCI trial randomised 2124 patients with AF who had undergone PCI to 1 of 3 …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.